Comparative Effectiveness of a Breath-Operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique - Tabular View

Tracking Information
First Received Date ^ICMJE	February 14, 2003
Last Updated Date	May 6, 2008
Start Date ^ICMJE	March 2003
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	Complete list of historical versions of study NCT00054964 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	Comparative Effectiveness of a Breath-Operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
Official Title ^ICMJE
Brief Summary	This study is designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard "press-and-breathe" inhaler.
Detailed Description
Study Phase	Phase II
Study Type ^ICMJE	Interventional
Study Design ^ICMJE	Treatment
Condition ^ICMJE	Asthma
Intervention ^ICMJE	Drug: Albuterol
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Completed
Enrollment ^ICMJE
Completion Date
Primary Completion Date
Eligibility Criteria ^ICMJE	Inclusion Criteria: Stable asthma Poor inhaler coordination technique. Exclusion Criteria: Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting beta-blockers, steroids other than those inhaled
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE

Administrative Information
NCT ID ^ICMJE	NCT00054964
Responsible Party
Study ID Numbers ^ICMJE	IXR-202-4-167
Study Sponsor ^ICMJE	Teva Global Respiratory Research LLC
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	Teva Global Respiratory Research LLC
Verification Date	May 2008
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP